C4a Level by RIA (Radioimmunoassay) is an important test in immunology, offering insights into the body's immune response, particularly in the context of inflammation and autoimmune disorders. The C4a component is a part of the complement system, a group of proteins in the blood that play a crucial role in the body's defense against infections and in the process of inflammation. When the complement system is activated in response to a threat like an infection, C4a is produced as a byproduct. Measuring the levels of C4a, therefore, can help in understanding if the complement system is overactive, which is often the case in autoimmune diseases or during certain allergic reactions.
The Radioimmunoassay (RIA) method used to measure C4a levels is a sensitive and specific technique. It involves using antibodies and radioactively labeled substances to detect and measure the concentration of C4a in the blood. This test is particularly useful in diagnosing conditions like systemic lupus erythematosus (SLE), where the complement system plays a significant role. Elevated levels of C4a might suggest active disease or an exacerbation in patients with SLE or other similar autoimmune conditions.
In addition to its use in autoimmune disorders, C4a levels can also be indicative of other conditions involving inflammation or immune response anomalies. For example, in cases of chronic fatigue syndrome, Lyme disease, or certain types of infections, abnormal C4a levels can provide valuable diagnostic information.
It's important to note that while the C4a Level by RIA is a powerful diagnostic tool, it should always be interpreted in the context of other clinical findings and tests. The results can vary depending on several factors, including the individual's overall health, the presence of other medical conditions, and specific laboratory techniques. Therefore, elevated or decreased C4a levels should be assessed by healthcare professionals who can consider the full clinical picture.
References:
Margery-Muir AA, Bundell C, Wetherall JD, Whidborne R, Martinez P, Groth DM. Insights on the relationship between complement component C4 serum concentrations and C4 gene copy numbers in a Western Australian systemic lupus erythematosus cohort. Lupus. 2018 Sep;27(10):1687-1696. doi: 10.1177/0961203318787039. Epub 2018 Jul 24. PMID: 30041577.
Ittiprasert W, Kantachuvesiri S, Pavasuthipaisit K, Verasertniyom O, Chaomthum L, Totemchokchyakarn K, Kitiyanant Y. Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations. J Autoimmun. 2005 Aug;25(1):77-84. doi: 10.1016/j.jaut.2005.04.004. PMID: 15998580.
Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, Birmingham DJ, Rovin BH, Yu CY. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun. 2004;7:98-132. doi: 10.1159/000075689. PMID: 14719377.
Traustadóttir KH, Steinsson K, Erlendsson K. C4AQ0 superimposed on a primary defect increases the susceptibility to systemic lupus erythematosus (SLE) in a family with association between C4AQ0 and SLE. J Rheumatol. 1998 Nov;25(11):2118-25. PMID: 9818652.
Wu YL, Yang Y, Chung EK, Zhou B, Kitzmiller KJ, Savelli SL, Nagaraja HN, Birmingham DJ, Tsao BP, Rovin BH, Hebert LA, Yu CY. Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res. 2008;123(1-4):131-41. doi: 10.1159/000184700. Epub 2009 Mar 11. PMID: 19287147; PMCID: PMC2709077.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.